nafamostat has been researched along with baicalein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Dodoala, S; Hema, K; Koganti, B; M, P; Reddy, GJ | 1 |
2 other study(ies) available for nafamostat and baicalein
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies.
Topics: Antiviral Agents; Benzamidines; Berberine; Binding Sites; COVID-19 Drug Treatment; Diterpenes; Flavanones; Flavonoids; Guanidines; Lactones; Lanosterol; Meloxicam; Models, Molecular; Proanthocyanidins; Protein Binding; SARS-CoV-2; Serine Endopeptidases; Serine Proteinase Inhibitors | 2021 |